IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

IMV Inc. („IMV” or the „Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced …

IMV Inc. ("IMV” or the "Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced ...